These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16631474)
1. Lack of TP53 and FMS gene mutations in children with myelodysplastic syndrome. Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Milasin J; Bunjevacki G; Damnjanovic T; Cvjeticanin S; Bunjevacki V Cancer Genet Cytogenet; 2006 Apr; 166(2):163-5. PubMed ID: 16631474 [TBL] [Abstract][Full Text] [Related]
2. [N-ras and fms gene mutation in idiopathic thrombocytopenic purpura and myelodysplasia]. Zhao HY; Hou M; Li XF; Ma DX; Liu QJ; Wang P Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):158-60. PubMed ID: 18788612 [TBL] [Abstract][Full Text] [Related]
3. Low frequency of NRAS and KRAS2 gene mutations in childhood myelodysplastic syndromes. Jekic B; Novakovic I; Lukovic L; Kuzmanovic M; Popovic B; Pastar I; Milasin J; Bunjevacki G; Bunjevacki V Cancer Genet Cytogenet; 2004 Oct; 154(2):180-2. PubMed ID: 15474158 [TBL] [Abstract][Full Text] [Related]
4. High sensitivity of detection of TP53 somatic mutations by fluorescence-assisted mismatch analysis. Tessitore A; Di Rocco ZC; Cannita K; Ricevuto E; Toniato E; Tosi M; Ficorella C; Frati L; Gulino A; Marchetti P; Martinotti S Genes Chromosomes Cancer; 2002 Sep; 35(1):86-91. PubMed ID: 12203794 [TBL] [Abstract][Full Text] [Related]
5. P53 mutation in advanced stage of primary myelodysplastic syndrome. Tang JL; Tien HF; Lin MT; Chen PJ; Chen YC Anticancer Res; 1998; 18(5B):3757-61. PubMed ID: 9854490 [TBL] [Abstract][Full Text] [Related]
6. Mutations in the p53 gene in myelodysplastic syndromes. Jonveaux P; Fenaux P; Quiquandon I; Pignon JM; Laï JL; Loucheux-Lefebvre MH; Goossens M; Bauters F; Berger R Oncogene; 1991 Dec; 6(12):2243-7. PubMed ID: 1766671 [TBL] [Abstract][Full Text] [Related]
7. NRAS, FLT3 and TP53 mutations in patients with myelodysplastic syndrome and a del(5q). Fidler C; Watkins F; Bowen DT; Littlewood TJ; Wainscoat JS; Boultwood J Haematologica; 2004 Jul; 89(7):865-6. PubMed ID: 15257941 [TBL] [Abstract][Full Text] [Related]
9. Two new polymorphisms but no mutations of the KIT gene in patients with myelodysplasia at positions corresponding to human FMS and murine W locus mutational hot spots. Bowen DT; Padua RA; Burnett AK; deCastro CM; Kaufman RE Leukemia; 1993 Nov; 7(11):1883-5. PubMed ID: 7694008 [TBL] [Abstract][Full Text] [Related]
10. Genetic aberrations in the development and subsequent progression of myelodysplastic syndrome. Misawa S; Horiike S; Kaneko H; Kashima K Leukemia; 1997 Apr; 11 Suppl 3():533-5. PubMed ID: 9209448 [TBL] [Abstract][Full Text] [Related]
11. A nonsense mutation (Arg-196-Term) in exon 6 of the human TP53 gene identified in small cell lung carcinoma. Hayes VM; Oosthuizen CJ; Kotze MJ; Marx MP; Buys CH Mol Cell Probes; 1996 Oct; 10(5):393-5. PubMed ID: 8910896 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature. Kulla A; Burkhardt K; Meyer-Puttlitz B; Teesalu T; Asser T; Wiestler OD; Becker AJ Acta Neuropathol; 2003 Apr; 105(4):328-32. PubMed ID: 12624785 [TBL] [Abstract][Full Text] [Related]
13. Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia. Mori N; Hidai H; Yokota J; Okada M; Motoji T; Oshimi K; Mizoguchi H Leuk Res; 1995 Nov; 19(11):869-75. PubMed ID: 8551805 [TBL] [Abstract][Full Text] [Related]
14. [Molecular abnormalities and clonality in myelodysplastic syndromes]. Fenaux P; Preudhomme C Pathol Biol (Paris); 1997 Sep; 45(7):556-60. PubMed ID: 9404479 [TBL] [Abstract][Full Text] [Related]
15. Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1. Maris JM; Wiersma SR; Mahgoub N; Thompson P; Geyer RJ; Hurwitz CG; Lange BJ; Shannon KM Cancer; 1997 Apr; 79(7):1438-46. PubMed ID: 9083167 [TBL] [Abstract][Full Text] [Related]
16. Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia. Preudhomme C; Lubin R; Lepelley P; Vanrumbeke M; Fenaux P Leukemia; 1994 Sep; 8(9):1589-91. PubMed ID: 8090036 [TBL] [Abstract][Full Text] [Related]
17. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome. Chen CY; Lin LI; Tang JL; Ko BS; Tsay W; Chou WC; Yao M; Wu SJ; Tseng MH; Tien HF Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630 [TBL] [Abstract][Full Text] [Related]
18. Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations. Watanabe T; Nobusawa S; Lu S; Huang J; Mittelbronn M; Ohgaki H J Neuropathol Exp Neurol; 2009 Feb; 68(2):210-5. PubMed ID: 19151620 [TBL] [Abstract][Full Text] [Related]
19. New recurrent deletions in the PPARgamma and TP53 genes are associated with childhood myelodysplastic syndrome. Silveira CG; Oliveira FM; Valera ET; Ikoma MR; Borgonovo T; Cavalli IJ; Tone LG; Rogatto SR Leuk Res; 2009 Jan; 33(1):19-27. PubMed ID: 18789822 [TBL] [Abstract][Full Text] [Related]
20. Mutational analysis of the KIT gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia. Lorenzo F; Nishii K; Monma F; Kuwagata S; Usui E; Shiku H Leuk Res; 2006 Oct; 30(10):1235-9. PubMed ID: 16533529 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]